Results 151 to 160 of about 2,327,860 (219)

Combined treatment of submacular hemorrhage with low-dose subretinal recombinant tissue plasminogen activator and intravitreal conbercept. [PDF]

BMC Ophthalmol
Ma Y, Rao S, Tan Y, Du H, Sun X.
europepmc   +1 more source

Relationships between structure and function of tissue-type plasminogen activator

, 1988
This mini-review deals with structure-function relationships of human-tissue type plasminogen activator. The enzyme consists of a single polypeptide chain of 527 amino acids.
Rijken, D.C.
core  

Early Drainage of Macula-Involving Massive Suprachoroidal Haemorrhage Assisted with Recombinant Tissue Plasminogen Activator May Lead to Better Visual Prognosis. [PDF]

Case Rep Ophthalmol
Khalil M, Schneiders M, Veckeneer M, Depla JA, Feron E, Saidkasimova S.   +5 more
europepmc   +1 more source

Recombinant tissue plasminogen activator treatment for COVID-19 associated ARDS and acute cor pulmonale. [PDF]

Int J Infect Dis, 2021
Kosanovic D, Yaroshetskiy AI, Tsareva NA, Merzhoeva ZM, Trushenko NV, Nekludova GV, Schermuly RT, Avdeev SN.   +7 more
europepmc   +1 more source

Synergistic effects of neuroprotective drugs with intravenous recombinant tissue plasminogen activator in acute ischemic stroke: A Bayesian network meta-analysis. [PDF]

PLoS One
Dang C, Wang Q, Zhuang Y, Li Q, Lu Y, Xiong Y, Feng L.   +6 more
europepmc   +1 more source

Thrombolysis with Systemic Recombinant Tissue Plasminogen Activator in Children: A Multicenter Retrospective Study [PDF]

Turk J Haematol, 2021
Zengin E, Sarper N, Yazal Erdem A, Odaman Al I, Sezgin Evim M, Yaralı N, Belen B, Akçay A, Türedi Yıldırım A, Karapınar TH, Güneş AM, Aylan Gelen S, Aylan Gelen S, Ören H, Olcay L, Baytan B, Gülen H, Öztürk G, Orhan MF, Oymak Y, Akpınar S, Tüfekçi Ö, Albayrak M, Tatlı Güneş B, Canpolat A, Özbek N.   +25 more
europepmc   +1 more source

Factors influencing the efficacy of recombinant tissue plasminogen activator: Implications for ischemic stroke treatment. [PDF]

PLoS One
Víteček J, Vítečková Wünschová A, Thalerová S, Gulati S, Kubala L, Capandová M, Hampl A, Robert Mikulík.   +7 more
europepmc   +1 more source

Clinical safety and outcome of recombinant tissue plasminogen activator in patients with stroke attributable to small artery occlusion: A protocol for systematic review and meta-analysis. [PDF]

Medicine (Baltimore), 2021
Ni LY, Tang JY.
europepmc   +1 more source

Using Rotational Thromboelastometry (ROTEM) to Evaluate Coagulation Status After Intrapleural Recombinant Tissue Plasminogen Activator (rtPA) Administration in Regional Anesthesia. [PDF]

Cureus
DeLeon A, Tureanu L, Vetter O, Liu T, Korula R, Garcia Tomas V, Asher Y.   +6 more
europepmc   +1 more source